高流量鼻导管氧疗在AECOPD伴呼吸衰竭中的治疗效果观察

Effect of High Flow Nasal Catheter Oxygen Therapy on AECOPD With Respiratory Failure

目的评析对AECOPD伴呼吸衰竭患者在医治过程中使用高流量鼻导管氧疗的临床价值。方法此研究的AECOPD伴呼吸衰竭患者选取时间为2018年1月—2020年1月,随机取126例,分为两组,一组是使用无创正压机械通气的对照组(n=63),另一组是使用高流量鼻导管氧疗的试验组(n=63),对治疗情况进行评价。结果使用高流量鼻导管氧疗的试验组患者氧疗持续时间显著少于使用无创正压机械通气的对照组(P<0.05),试验组间断氧疗次数更少(P<0.05),平均住院时间较短(P<0.05),试验组治疗效果更明显(P<0.05)。结论对AECOPD伴呼吸衰竭患者治疗时使用高流量鼻导管氧疗可起到较好治疗效果。

Objective To evaluate the clinical value of high flow oxygen therapy for AECOPD patients with respiratory failure.Methods From January 2018 to January 2020,a total of 126 patients with AECOPD and respiratory failure were randomly divided into two groups:the control group(n=63)using noninvasive positive pressure mechanical ventilation and the experimental group(n=63)using high flow nasal catheter oxygen therapy.Results Patients in experimental group with high flow nasal catheter oxygen therapy was significantly less than controls without invasive positive pressure mechanical ventilation (P<0.05), less intermittent oxygen therapy (P<0.05), shorter mean hospitalization (P<0.05) and more effective (P<0.05). Conclusion High flow oxygen therapy with nasal catheter can be used in the treatment of AECOPD with respiratory failure.